Your browser doesn't support javascript.
loading
Elevated Adipocyte Membrane Phospholipid Saturation Does Not Compromise Insulin Signaling.
Palmgren, Henrik; Petkevicius, Kasparas; Bartesaghi, Stefano; Ahnmark, Andrea; Ruiz, Mario; Nilsson, Ralf; Löfgren, Lars; Glover, Matthew S; Andréasson, Anne-Christine; Andersson, Liselotte; Becquart, Cécile; Kurczy, Michael; Kull, Bengt; Wallin, Simonetta; Karlsson, Daniel; Hess, Sonja; Maresca, Marcello; Bohlooly-Y, Mohammad; Peng, Xiao-Rong; Pilon, Marc.
Affiliation
  • Palmgren H; Bioscience Metabolism, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Petkevicius K; Bioscience Metabolism, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Bartesaghi S; Translational Science and Experimental Medicine, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Ahnmark A; Bioscience Metabolism, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Ruiz M; Department of Chemistry and Molecular Biology, University of Gothenburg, Gothenburg, Sweden.
  • Nilsson R; Translational Science and Experimental Medicine, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Löfgren L; Translational Science and Experimental Medicine, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Glover MS; Dynamic Omics, Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD.
  • Andréasson AC; Bioscience Cardiovascular, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Andersson L; Animal Science & Technologies, Clinical Pharmacology & Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Becquart C; Department of Chemistry and Molecular Biology, University of Gothenburg, Gothenburg, Sweden.
  • Kurczy M; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Kull B; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Wallin S; Bioscience Cardiovascular, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Karlsson D; Bioscience Metabolism, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Hess S; Bioscience Metabolism, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Maresca M; Dynamic Omics, Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD.
  • Bohlooly-Y M; Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Peng XR; Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Pilon M; Bioscience Metabolism, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Diabetes ; 72(10): 1350-1363, 2023 10 01.
Article de En | MEDLINE | ID: mdl-36580483

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Phospholipides / Insuline Limites: Animals / Humans Langue: En Journal: Diabetes Année: 2023 Type de document: Article Pays d'affiliation: Suède Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Phospholipides / Insuline Limites: Animals / Humans Langue: En Journal: Diabetes Année: 2023 Type de document: Article Pays d'affiliation: Suède Pays de publication: États-Unis d'Amérique